Accumulated Other Comprehensive Income (Loss), Net of Tax of ALTEROLA BIOTECH INC. from 31 Mar 2024 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
ALTEROLA BIOTECH INC. quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD history and change rate from 31 Mar 2024 to 30 Jun 2024.
  • ALTEROLA BIOTECH INC. Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending 30 Jun 2024 was $35,629.
Source SEC data
View on sec.gov
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)

ALTEROLA BIOTECH INC. Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $35,629 30 Jun 2024 10-Q/A 25 Nov 2024 2025 Q1
Q1 2024 $39,860 31 Mar 2024 10-Q/A 25 Nov 2024 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.